H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating
MT NewswiresMar 22 23:14
OKYO Pharma Analyst Ratings
BenzingaMar 22 23:04
Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)
TipRanksMar 22 21:00
Buy Rating Affirmed for OKYO Pharma Amid OK-101's Promising Phase 2 Results and Increased Approval Probability
TipRanksJan 8 21:25
HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $5
BenzingaJan 8 21:17
OKYO Pharma Analyst Ratings
BenzingaJan 8 21:17
HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $4 Price Target
BenzingaDec 5, 2023 19:49
OKYO Pharma Analyst Ratings
BenzingaDec 5, 2023 19:45
HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4
BenzingaNov 2, 2023 19:07
OKYO Pharma Analyst Ratings
BenzingaNov 2, 2023 19:06
No Data
No Data